Obsessive-compulsive disorder

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Veale, David ^a   Roberts, Alison ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE THERAPY; HUMANS; OBSESSIVE BEHAVIOR; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 84898652008     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2183     Document Type: Review

References (37)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
2. Bobes J, Gonzalez MP, Bascaran MT, Arango C, Saiz PA, Bousono M. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry 2001;16:239-45.
3. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:61727.
4. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357-76.
5. Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry 2001;179:324-9.
6. Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just "little adults"? J Clin Invest 2009;119:737-46.
7. Singer HS, Gilbert DL, Wolf DS, Mink JW, Kurlan R. Moving from PANDAS to CANS. J Pediatr 2012;160:72531.
8. Veale D. Over-valued ideas: a conceptual analysis. Behav Res Ther 2002;40:383-400.
9. American Psychiatric Association. DSM 5. APA, 2013.
10. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. WHO, 1992.
11. Palumbo D, Kurlan R. Complex obsessive compulsive and impulsive symptoms in Tourette's syndrome. Neuropsychiatr Dis Treat 2007;3:687-93.
12. National Institute for Health and Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. NICE, 2005.
13. Veale D, Freeston M, Krebs G, Heyman I, Salkovskis P. Risk assessment and management in obsessive-compulsive disorder. Adv Psychiatr Treat 2009;15:332-43.
14. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010;12:149-63.
15. Grisham JR, Fullana MA, Mataix-Cols D, Moffitt TE, Caspi A, Poulton R. Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. Psychol Med 2011;41:2495-506.
16. Pace SM, Thwaites R, Freeston MH. Exploring the role of external criticism in obsessive compulsive disorder: a narrative review. Clin Psychol Rev 2011;31:361-70.
17. Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther 1997;35:667-81.
18. Russell EJ, Fawcett JM, Mazmanian D. Risk of obsessive-compulsive disorder in pregnant and postpartum women: a meta-analysis. J Clin Psychiatry 2013;74:377-85.
19. Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 2004;113:90711.
20. Susan E. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut 2012;2:113.
21. Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci 2010;12:131-48.
22. Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011;37:81121.
23. Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M. Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry 2011;2:70.
24. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004;161:221521.
25. Russell AJ, Mataix-Cols D, Anson M, Murphy DG. Obsessions and compulsions in Asperger syndrome and high-functioning autism. Br J Psychiatry 2005;186:525-8.
26. Hollander E, Stein D, Kwon J, Rowland C, Wong C, Broatch J, et al. Psychosocial function and economic costs of obsessive-compulsive disorder. CNS Spectrum 1997;2:1525.
27. Roth AFP. What works for whom? A critical review of psychotherapy research. Guilford Press, 1996.
28. Foa EB, Emmelkamp PMG. Failures in behaviour therapy. Wiley, 1983.
29. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006;51:40716.
30. Olatunji BO, Davis ML, Powers MB, Smits JA. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res 2013;47:33-41.
31. Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 2013;70:1190-9.
32. Komossa K, Depping AM, Meyer M, Kissling W, Leucht S. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010;(12):CD008141.
33. National Institute for Health and Care Excellence. Obsessive-compulsive disorder: evidence update 2013. NICE, 2013.
34. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354:1153-8.
35. Lovell K, Bee P. Optimising treatment resources for OCD: a review of the evidence base for technology-enhanced delivery. J Ment Health 2011;20:525-42.
36. Herbst N, Voderholzer U, Stelzer N, Knaevelsrud C, Hertenstein E, Schlegl S, et al. The potential of telemental health applications for obsessive-compulsive disorder. Clin Psychol Rev 2012;32:454-66.
37. Oldfield VB, Salkovskis PM, Taylor T. Time-intensive cognitive behaviour therapy for obsessive-compulsive disorder: a case series and matched comparison group. Br J Clin Psychol 2011;50:718.